
OWL Lifesciences provides a platform to accelerate discovery and testing of CNS therapeutic targets. It combines systems biology, AI, and animal-free experimental data to model targets and carriers. The company uses in vitro vascularised assembloids and biohybrid computing as core technologies. This B2B platform serves pharma and biotech developers seeking CNS solutions. The approach aims to scale translational research and broaden unmet CNS condition coverage.

OWL Lifesciences provides a platform to accelerate discovery and testing of CNS therapeutic targets. It combines systems biology, AI, and animal-free experimental data to model targets and carriers. The company uses in vitro vascularised assembloids and biohybrid computing as core technologies. This B2B platform serves pharma and biotech developers seeking CNS solutions. The approach aims to scale translational research and broaden unmet CNS condition coverage.